REGISTERED NUMBER: 07803067 (England and Wales)

FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2025

FOR

KHARMEL COCHRANE CASTING LTD

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

Ms K Cochrane

A Gravett

REGISTERED OFFICE:

10 London Mews

London

W2 1HY

REGISTERED NUMBER:

07803067 (England and Wales)

ACCOUNTANTS:

Stein Richards

Chartered Accountants

10 London Mews

Paddington

LONDON

W2 1HY

FIXED ASSETS

Tangible assets

4

37,000

49,331

CURRENT ASSETS

Debtors

5

473,445

275,256

Cash at bank

34,550

52,340

507,995

327,596

CREDITORS

Amounts falling due within one year

6

499,259

313,156

NET CURRENT ASSETS

8,736

14,440

TOTAL ASSETS LESS CURRENT LIABILITIES

45,736

63,771

CREDITORS

Amounts falling due after more than one year

7

45,650

63,790

NET ASSETS/(LIABILITIES)

86

(19

)

CAPITAL AND RESERVES

Called up share capital

8

100

100

Retained earnings

(14

)

(119

)

SHAREHOLDERS' FUNDS

86

(19

)

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 28 August 2025 and were signed on its behalf by:

Ms K Cochrane - Director

1.	STATUTORY INFORMATION

Kharmel Cochrane Casting Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern

After reviewing the company's forecasts and projections, the directors have reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Turnover

Turnover represents net invoiced services, excluding value added tax.

Rendering of services

Revenue for providing services are recognised when the service has been completed.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Fixtures and fittings

-

25% reducing balance

Computer equipment

-

33.33% reducing balance

Financial instruments

The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities such as trade and other debtors and creditors and loans to related parties.

The basic financial debtors and liabilities as listed above are initially recognised at transaction price, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future payments / receipts discounted at a market rate of interest. Such instruments are subsequently carried at amortised cost using the effective interest method, less any impairment. An impairment review is undertaken annually at the balance sheet date.

Foreign currencies

Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 7 (2024 - 7 ) .

4.	TANGIBLE FIXED ASSETS

Fixtures

and

Motor

Computer

fittings

vehicles

equipment

Totals

£

£

£

£

COST

At 1 April 2024

and 31 March 2025

12,949

56,387

1,645

70,981

DEPRECIATION

At 1 April 2024

5,916

14,097

1,637

21,650

Charge for year

1,758

10,573

-

12,331

At 31 March 2025

7,674

24,670

1,637

33,981

NET BOOK VALUE

At 31 March 2025

5,275

31,717

8

37,000

At 31 March 2024

7,033

42,290

8

49,331

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Trade debtors

31,844

165,956

Directors' current accounts

330,338

66,296

Tax

109,835

43,004

Prepayments

1,428

-

473,445

275,256

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.3.25

31.3.24

£

£

Bank loans and overdrafts

10,000

10,000

Hire purchase contracts

8,139

8,139

Trade creditors

9,897

5,973

Tax

383,552

203,206

Social security and other taxes

32,207

9,012

VAT

49,564

67,049

Other creditors

-

1,317

Accrued expenses

5,900

8,460

499,259

313,156

7.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

31.3.25

31.3.24

£

£

Bank loans - 1-2 years

3,333

10,000

Bank loans - 2-5 years

-

3,334

Hire purchase contracts

42,317

50,456

45,650

63,790

8.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

31.3.25

31.3.24

value:

£

£

100

Ordinary Shares

1

100

100

9.	DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2025 and 31 March 2024:

31.3.25

31.3.24

£

£

Ms K Cochrane

Balance outstanding at start of year

66,296

105,858

Amounts advanced

264,041

-

Amounts repaid

-

(39,562

)

Amounts written off

-

-

Amounts waived

-

-

Balance outstanding at end of year

330,337

66,296